Other Issues:
previous
|
next
|
latest
|
archive
Volume 3(4); Fall 2001
Technique Update
Current Clinical Applications of the
111
In-capromab Pendetide Scan (ProstaScint® Scan, Cyt-356)
Misop Han and Alan W Partin
Rev Urol.
2001 Fall;
3
(4)
: 165–171.
PMCID:
PMC1476063
|
Abstract
|
Full Text
|
PDF–428K
|
Pediatric Urology
Update on Vesicoureteral Reflux: Pathogenesis, Nephropathy, and Management
Ross M Decter
Rev Urol.
2001 Fall;
3
(4)
: 172–178.
PMCID:
PMC1476059
|
Abstract
|
Full Text
|
PDF–332K
|
Treatment Update
Prostate Cancer Gene Therapy—What Have We Learned and Where Are We Going?
Bob Djavan and Yasutomo Nasu
Rev Urol.
2001 Fall;
3
(4)
: 179–186.
PMCID:
PMC1476064
|
Abstract
|
Full Text
|
PDF–77K
|
The Epidemiology of Acute Urinary Retention in Benign Prostatic Hyperplasia
Claus G Roehrborn
Rev Urol.
2001 Fall;
3
(4)
: 187–192.
PMCID:
PMC1476058
|
Abstract
|
Full Text
|
PDF–79K
|
Meeting Review
Best of the 2001 AUA Annual Meeting:
Highlights of the 2001 Annual Meeting of the American Urological Association June 2–7, 2001, Anaheim, CA
Rev Urol.
2001 Fall;
3
(4)
: 193–206.
PMCID:
PMC1476062
|
Full Text
|
PDF–231K
|
Case Review
Obstructive Uropathy Secondary to Ureteroinguinal Herniation
Karyn S Eilber, Stephen J Freedland, and Jacob Rajfer
Rev Urol.
2001 Fall;
3
(4)
: 207–208.
PMCID:
PMC1476065
|
Abstract
|
Full Text
|
PDF–164K
|
Reviewing the Literature
Overactive Bladder
A Comparison of Anticholinergic Therapies in the Treatment of Overactive Bladder
Herbert Lepor
Rev Urol.
2001 Fall;
3
(4)
: 209.
PMCID:
PMC1476061
|
Full Text
|
PDF–80K
|
Urologic Oncology
Biomarkers for Early Detection and Optimized Treatment for Transitional Cell Carcinoma
Stephen J Freedland, Matthew H. T Bui, Debby Chao, Allan J Pantuck, Amnon Zisman, and Arie S Belldegrun
Rev Urol.
2001 Fall;
3
(4)
: 210–212.
PMCID:
PMC1476060
|
Full Text
|
PDF–80K
|
Infertility
Men Undergoing ICSI: Y We Do What We Do
Jacob Rajfer
Rev Urol.
2001 Fall;
3
(4)
: 213.
PMCID:
PMC1476057
|
Full Text
|
PDF–80K
|
Other Issues:
previous
|
next
|
latest
|
archive